TY - CHAP M1 - Book, Section TI - Myocardial Revascularization with Percutaneous Devices A1 - Wilson, James M. A1 - Willerson, James T. A2 - Cohn, Lawrence H. A2 - Adams, David H. PY - 2017 T2 - Cardiac Surgery in the Adult, 5e AB - At its height, the success of surgical coronary revascularization spurred improvement in catheter-based technology—first for imaging quality, and later for attempted therapy. In 1974, Andreas Gruentzig completed the development of a double-lumen balloon catheter that was miniaturized for use in coronary arteries. Soon afterward, techniques for percutaneous transluminal coronary angioplasty (PTCA) expanded as technical breakthroughs were applied to subselective catheters, devices, guidewires, balloon materials, coronary stents, and circulatory support. Currently, trial evidence attests that percutaneous therapy is useful as a treatment in patients with poorly controlled angina whose anatomy does not imply a survival benefit from revascularization, and for emergency revascularization during ST-segment elevation myocardial infarction (MI). Surgical and percutaneous revascularization, however, cannot be considered equivalent.1 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesssurgery.mhmedical.com/content.aspx?aid=1144151828 ER -